BioSpace News Archive

Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today announced that data from its landmark PROspective study for SymPtomatic relief of Essential tremor with Cala Therapy (PROSPECT), was published in Tremor and Other Hyperkinetic Movements

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its Hand Sanitizer Analyzer instrument can be used to test for the presence of methanol in alcohol-based hand sanitizer products with pass/fail results delivered in 30 seconds or less. Recent warnings and recal

Novant Health today announced it is the first in the Carolinas to offer a scalpel-free treatment for essential tremor and medication-refractory tremor-dominant Parkinson’s disease.

The Frederick National Laboratory’s Nanotechnology Characterization Laboratory recently supported a first-of-its-kind study examining whether nanoparticles used for drug delivery, vaccines, and biomedical imaging were toxic over an extended period of time.

Centinel Spine ® , LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced Varun Gandhi as Chief Financial Officer effective August 17, 2020 . Mr. Gandhi succeeds Jeff Stello of Charlestown Capital Partners, who had served as interim CFO since late 2019.

Cureatr, Inc., a comprehensive medication management (CMM) technology and services company, today announced the creation of its Strategic Advisory Board (SAB) to provide external expertise, insight, and guidance to the company’s management in regards to its business development, clinical strategy and direction, research and development activities and solution portfolio.

During the ASPC annual business meeting during the recent 2020 ASPC Virtual Summit on CVD Prevention, Peter P. Toth, MD, PhD, FASPC was officially elected as the President of the American Society for Preventive Cardiology (ASPC).

Results from genomic testing of a cancer patient’s biopsy tissue can help guide treatment decisions, depending on the types of gene mutations found. But as it spreads or stops responding to treatment, the cancer changes and develops new mutations. Insights gained from the biopsy of the primary tumor may no longer be relevant in determining next steps.

Third FDA-Approved Therapy in Just Over a Year for Neuromyelitis Optica Spectrum Disorder Gives Patients Another Treatment Option

Illinois Bone & Joint Institute (IBJI), the largest independent, physician-owned orthopedic practice in Illinois, welcomes Orthopaedic Surgery Specialists (OSS) to our practice as of August 1, 2020